For: | Li NL, Nie H, Yu QW, Zhang JY, Ma AL, Shen BH, Wang L, Bai J, Chen XH, Zhou T, Zhang DQ. Role of soluble Fas ligand in autoimmune diseases. World J Gastroenterol 2004; 10(21): 3151-3156 [PMID: 15457562 DOI: 10.3748/wjg.v10.i21.3151] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i21/3151.htm |
Number | Citing Articles |
1 |
|
2 |
Wan-Uk Kim, Seung-Ki Kwok, Kyung-Hee Hong, Seung-Ah Yoo, Jin-Sun Kong, Jongseon Choe, Chul-Soo Cho. Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis
. Arthritis Research & Therapy 2007; 9(2) doi: 10.1186/ar2181
|
3 |
K. Duus, R. T. Pagh, U. Holmskov, P. Højrup, S. Skov, G. Houen. Interaction of Calreticulin with CD40 Ligand, TRAIL and Fas Ligand. Scandinavian Journal of Immunology 2007; 66(5): 501 doi: 10.1111/j.1365-3083.2007.01999.x
|
4 |
Der-Yuan Chen, Joung-Liang Lan, Fang-Ju Lin, Tsu-Yi Hsieh. Elevated levels of soluble Fas (APO-1, CD95), soluble Fas ligand, and matrix metalloproteinase-3 in sera from patients with active untreated adult onset Still’s disease. Clinical Rheumatology 2007; 26(3): 393 doi: 10.1007/s10067-006-0378-z
|
5 |
Pervin Imirzalioğlu, Sina Uçkan, Nurhan Güler, Ayşegül Haberal, Duygu Uçkan. Synovial apoptosis in temporomandibular joint disc displacement without reduction. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2009; 108(5): 693 doi: 10.1016/j.tripleo.2009.05.030
|
6 |
Elham Masoumi, Asad Mirzaei, Haniyeh Ghaffari-Nazari, Sahar Tahaghoghi-Hajghorbani, Seyed Amir jalali, Jalil Tavakkol-Afshari*. Serum Levels of Soluble Fas and Fas Ligand in Iranian Women with Pre-eclampsia. Reports of Biochemistry and Molecular Biology 2021; 9(4): 394 doi: 10.52547/rbmb.9.4.394
|
7 |
M. Sahin, O. Aydıntug, S.E. Tunc, H. Tutkak, M. Nazıroğlu. Serum soluble Fas levels in patients with autoimmune rheumatic diseases. Clinical Biochemistry 2007; 40(1-2): 6 doi: 10.1016/j.clinbiochem.2006.09.003
|
8 |
Mevlut Ceri, Selman Unverdi, Mehmet Senes, Mustafa Altay, Rahmi Yilmaz, Dogan Yucel, Murat Duranay. Serum soluble fas ligand levels in familial Mediterranean fever. Renal Failure 2013; 35(6): 835 doi: 10.3109/0886022X.2013.794660
|
9 |
Haiyu Zhang, Fei Xiao, Yijun Liu, Ding Zhao, Yuxing Shan, Yanfang Jiang. A higher frequency of peripheral blood activated B cells in patients with non-traumatic osteonecrosis of the femoral head. International Immunopharmacology 2014; 20(1): 95 doi: 10.1016/j.intimp.2014.02.016
|
10 |
Keerthi Kurma, Andrea Boizard-Moracchini, Gael Galli, Mickael Jean, Pierre Vacher, Patrick Blanco, Patrick Legembre. Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1876(2): 188596 doi: 10.1016/j.bbcan.2021.188596
|
11 |
Ekaterina Telegina, Tatiana Reshetnyak, Anna Moshnikova, Olga Proussakova, Alexandra Zhukova, Alla Kuznetsova, Alexei Ivanov, Michail Paltsev, Igor Beletsky. A possible role of Fas-ligand-mediated “reverse signaling” in pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Immunology Letters 2009; 122(1): 12 doi: 10.1016/j.imlet.2008.10.003
|
12 |
Anupam Verma, Prashant Pandey, Dheeraj Khetan, Rahul Katharia, Rajendra Chaudhary, Amita Aggarwal. Differential patterns of serum Fas ligand levels in blood donors. Transfusion 2008; 48(10): 2264 doi: 10.1111/j.1537-2995.2008.01866.x
|
13 |
Yan-Hui Ma, Wei-Zhi Cheng, Fang Gong, An-Lun Ma, Qi-Wen Yu, Ji-Ying Zhang, Chao-Ying Hu, Xue-Hua Chen, Dong-Qing Zhang. Active chinese mistletoe lectin-55 enhances colon cancer surveillance through regulating innate and adaptive immune responses. World Journal of Gastroenterology 2008; 14(34): 5274-5281 doi: 10.3748/wjg.14.5274
|
14 |
Patricia Verónica Jacobo, Mónica Fass, Cecilia Valeria Pérez, Sabrina Jarazo-Dietrich, Livia Lustig, María Susana Theas. Involvement of soluble Fas Ligand in germ cell apoptosis in testis of rats undergoing autoimmune orchitis. Cytokine 2012; 60(2): 385 doi: 10.1016/j.cyto.2012.07.020
|
15 |
Jiao Luo, Ying Wang, Bing Yu, Hongyan Qian, Yan He, Guixiu Shi. A Potential of sFasL in Preventing Gland Injury in Sjogren’s Syndrome. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/5981432
|
16 |
Heba Abuhussein, Jill D. Bashutski, Darya Dabiri, Sindhu Halubai, Mary Layher, Christine Klausner, Huwaida Makhoul, Yvonne Kapila. The Role of Factors Associated With Apoptosis in Assessing Periodontal Disease Status. Journal of Periodontology 2014; 85(8): 1086 doi: 10.1902/jop.2013.130095
|
17 |
Thitiya Sae‐jung, Nitigorn Leearamwat, Nichakarn Chaiseema, Panjana Sengprasert, Srihatach Ngarmukos, Pongsak Yuktananda, Aree Tanavalee, Nattiya Hirankarn, Rangsima Reantragoon. The infrapatellar fat pad produces interleukin‐6‐secreting T cells in response to a proteoglycan aggrecan peptide and provides dominant soluble mediators different from that present in synovial fluid. International Journal of Rheumatic Diseases 2021; 24(6): 834 doi: 10.1111/1756-185X.14126
|
18 |
Nayira Ahmed Abdel Baky, Laila Fadda, Nouf M. Al-Rasheed, Nawal M. Al-Rasheed, Azza Mohamed, Hazar Yacoub. Neuroprotective effect of carnosine and cyclosporine-A against inflammation, apoptosis, and oxidative brain damage after closed head injury in immature rats. Toxicology Mechanisms and Methods 2016; 26(1): 1 doi: 10.3109/15376516.2015.1070224
|